Objective: The purpose of this study is to document changes in attenuation values on triphasic MDCT of histologically or surgically proven cystic renal lesions.
Materials And Methods: A retrospective study of all renal lesions greater than 1 cm that underwent triphasic MDCT was performed in 90 patients before partial nephrectomy. Three reviewers independently measured the mean attenuation of all lesions in three phases (unenhanced, corticomedullary, and parenchymal) in a blinded retrospective fashion. Forty-three lesions identified at CT in 27 patients had pathologic or surgical confirmation as cysts (fluid-filled lesions). Mean change in attenuation between phases was calculated and correlated with size, unenhanced density, and percentage of the lesion exophytic from renal parenchyma. All scans were obtained after 150 mL of nonionic contrast material was injected at 3 mL/sec. Scanning delays were 30-40 sec (corticomedullary phase) and 120 sec (parenchymal phase).
Results: The mean change in attenuation coefficient of the cysts from the unenhanced to the parenchymal phase was -1.8 H (SD, +/- 4.4 H); from the unenhanced to the corticomedullary phase was -2.3 H (+/- 3.9 H); and from the corticomedullary to the parenchymal phase was 0.6 H (+/- 4.2 H). No cyst increased more than 10 H between the unenhanced and the parenchymal phases; more than 95% of cysts increased less than 8 H between any scanning phases. No significant difference was seen in enhancement related to lesion size (p > 0.054), unenhanced attenuation (p > 0.255), or percentage of the lesion that was exophytic (p > 0.124).
Conclusion: The attenuation coefficient of a cystic renal lesion increased by no more than 10 H among the unenhanced, corticomedullary, and parenchymal phase scans.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2214/ajr.182.2.1820405 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
α-SMA cancer-associated fibroblasts increased tumor enhancement ratio on contrast-enhanced multidetector-row computed tomography in stages I-III colon cancer.
J Gastroenterol Hepatol
December 2023
Department of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Background And Aim: Our prior research revealed that the tumor enhancement ratio (TER) on triphasic abdominal contrast-enhanced MDCT (CE-MDCT) scans was a prognostic factor for patients with stages I-III colon cancer. Building upon this finding, the present study aims to investigate the proteomic changes in colon cancer patients with varying TER values.
Methods: TER was analyzed on preoperative triphasic CE-MDCT scans of 160 stages I-III colon cancer patients.
Multi-detector computed tomography evaluation of synchronous hepatocellular carcinoma and other solid malignancies.
Clin Exp Hepatol
September 2022
Faculty of Medicine, Mansoura University, Egypt.
Aim Of The Study: To review the findings of multi-detector computed tomography (MDCT) in synchronous hepatocellular carcinoma (HCC) and other solid malignancies.
Material And Methods: A total of 74 cases were included in this retrospective analysis, all of them confirmed with a diagnosis of synchronous HCC and other solid malignancies. They were 41 women and 33 men (mean age, 63.
Automated detection of the contrast phase in MDCT by an artificial neural network improves the accuracy of opportunistic bone mineral density measurements.
Eur Radiol
March 2022
Department of Neuroradiology, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str 22, 81675, Munich, Germany.
Objectives: To determine the accuracy of an artificial neural network (ANN) for fully automated detection of the presence and phase of iodinated contrast agent in routine abdominal multidetector computed tomography (MDCT) scans and evaluate the effect of contrast correction for osteoporosis screening.
Methods: This HIPPA-compliant study retrospectively included 579 MDCT scans in 193 patients (62.4 ± 14.
Investigating Dual-Energy CT Post-Contrast Phases for Liver Iron Quantification: A Preliminary Study.
Dose Response
June 2021
IRCCS SDN, Naples, Italy.
Background And Purpose: Quantification of hepatic virtual iron content (VIC) by using Multidetector Dual Energy Computed Tomography (DECT) has been recently investigated since this technique could offer a good compromise between accuracy and non-invasiveness for liver iron content quantification. The aim of our study is to investigate differences in VIC at different DECT time points (namely baseline and arterial, venous and tardive phases), identifying the most reliable and also exploring the underlying temporal trend of these values.
Materials And Methods: Eleven patients who underwent DECT examination and were characterized by low liver fat content were included in this retrospective study.
MRI vs. CT for the Detection of Liver Metastases in Patients With Pancreatic Carcinoma: A Comparative Diagnostic Test Accuracy Systematic Review and Meta-Analysis.
J Magn Reson Imaging
January 2021
Department of Diagnostic Imaging, Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Background: The detection of liver metastases is important for pancreatic cancer curative treatment eligibility. The data suggest that magnetic resonance imaging (MRI) is more sensitive than computed tomography (CT) for the diagnosis of pancreatic cancer liver metastases. However, MRI is not currently recommended in multiple published guidelines.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!